TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
Bond investors know inflation impacts returns. So Hermes' Fraser Lundie is watching US jobs fi...
With the price of oil up more than 50% over the past year, is it time for investors to start b...
This trio of AIM-listed industrial equipment manufacturers have been overlooked as the oil pri...
VIDEO: Thematic investing requires an ounce of hope about our ability to innovate and solve probl...
Spiking food demand and a rapidly changing climate make investing in the global food business bot...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Passive thematics funds are not without risks but do come with a lower upfront cost
VIDEO: Michael Born, research analyst at Morningstar, says falling inflation and lower valuation ...
Hype is a problem in thematic investing. Managers in the healthcare, tech and energy sectors disc...
The progress in renewable energy has been rapid, but investing in the sector has been much less p...
Flagship ARK Innovation ETF is now available in Europe, as well as funds focused on genomics, AI ...
Glenn Freeman is Senior Editor for Morningstar Australia